Amplify Weight Loss Drug & Treatment ETF

THNR
$26.24 (- $0.07 - 0.27%)
Last updated: 2026-07-10 11:40 UTC
THNR Metrics
Exchange
🇺🇸 NYSE ARCX
NYSE ArcaUnited StatesAmerica/New_York
SectorHealth
IndustryAmplify ETFs
ISINUS0321085328
CUSIP032108532
Market Price26.24
Dividend Yield 1.0%
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyAnnually
P/E Ratio18.88
EPS1.38
Market CapN/A
Book ValueN/A
Price to BookN/A
BetaN/A
52w High26.27
52w Low18.56
Next Earnings DateN/A

Amplify Weight Loss Drug & Treatment ETF trades under ticker THNR on NYSE as an ETF. Use this page to review its market price, share price, dividends, and price history. The page also shows Health exposure. Identifiers: ISIN US0321085328, CUSIP 032108532.

Related researchTHNR ETF priceTHNR share priceTHNR dividend historyTHNR dividend yieldAmplify Weight Loss Drug & Treatment ETF dividend historyAmplify Weight Loss Drug & Treatment ETF dividend yield032108532Amplify Weight Loss Drug & Treatment ETFAmplify Weight Loss Drug & Treatment ETF share price
About the Company
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies expected to economically benefit from weight loss drug development. The index includes pharmaceutical manufacturers, manufacturers of combination therapies and telehealth providers who provide access to Amylin agonists and analogs or GLP-1 agonists and analogs, including dual GLP-1 agonists and analogs. The fund is non-diversified.
Price History